Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Medicines from the Sea

24.03.2009
For the first time, Norwegian scientists have managed to produce completely new antibiotics from bacteria found in the sea. The eleven species of bacteria that create substances that kill cancerous cells and three other bacteria that produce new antibiotics were discovered by scientists at Norwegian University of Science and Technology (NTNU) and SINTEF. In collaboration with research groups in Moscow and the University of Bergen, they have made breakthroughs in the field of biotechnology.

Never before have Norwegian scientists carried out the entire process from gathering bacteria from the fjords to presenting completely new interesting substances in bottles. Behind their success lies a long and painstaking process of screening, cultivation, isolation and testing.

However, it will still take some time before they can be sure that the process will continue to the phases of commercialisation and medicine production. The NTNU and SINTEF researchers have been bioprospecting for five or six years, searching for interesting substances that are produced by marine bacteria. The wide range of expertise of this research group makes it unique, as it brings together competence in physiology and genetics, and has access to modern screening and fermentation laboratories.

The pace of the process has risen during the past few months, since the recruitment of Professor Stein Ove Døskeland’s group at the University of Bergen, one of the best groups around in this field. The scientists have also had bacterial fractions tested in Russia.

Many of the bacteria that have been brought up from the Trondheim Fjord have antibiotic functions, but most of these are already known, and are therefore of no interest. New compounds that can be patented are most interesting. “Substances with a new chemical structure and, we hope, with a different mechanism of action than we already know of, could be extremely valuable, for example in fighting cancer. This is why we need more candidate structures. Not all of them can be developed into new medicines, but if we are successful with one or two of them, we will be quite happy,” says NTNU professor Sergey Zotchev.

Recent focus on a few selected bacteria has led to these exciting findings. In Bergen and Moscow, the 11 anti-cancer substances have been tested against leukemias and stomach, colon and prostate cancers. “We have found that cancerous cells have been killed, while normal cells survive, and that individual extracts act on different types of cancer cells,” says senior scientist Håvard Sletta of SINTEF. “However, we still have not identified the active substances in the compounds produced by the bacteria”.

Meticulous laboratory experiments have enable the scientists to identify the chemical structure of one of the three substances that can be used as antibiotics, and which they now know act against multiresistant bacteria. Towards the end of March, this substance is due to be tested on animals in Moscow. If the results turn out to be positive, the way will be clear for a patent application.

| SINTEF News
Further information:
http://www.sintef.no/Home/Press-Room/Research-News/Medicines-from-the-Sea2/
http://www.kooperation-international.de

More articles from Life Sciences:

nachricht 'Lipid asymmetry' plays key role in activating immune cells
20.02.2018 | Biophysical Society

nachricht New printing technique uses cells and molecules to recreate biological structures
20.02.2018 | Queen Mary University of London

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

'Lipid asymmetry' plays key role in activating immune cells

20.02.2018 | Life Sciences

MRI technique differentiates benign breast lesions from malignancies

20.02.2018 | Medical Engineering

Major discovery in controlling quantum states of single atoms

20.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>